Correct, and the other ‘big dollar pipe dream’ is TAVR which is a proven technology with 2 incumbents with approved devices currently owning 80% of the market. This is no pipe dream - we are now shaping up to become a disruptor in this multi-billion dollar (and growing rapidly) space.
TMVR is a different story (which I’m sorry about for Kogarahboy on a personal note), but there is $0.00 of TMVR possibilities baked into Admedus’ SP so it’s a moot point. All it is is a few CC sales to support 4C medicals trials (and the free upside that would come if their device is FDA approved with our tissue as an integral part of the device registration)
TAVR gains interest at JPM, page-49
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.35 |
Change
0.200(1.32%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.35 | $15.35 | $15.35 | $9.978K | 650 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 12 | $15.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.30 | 300 | 1 |
View Market Depth
| Last trade - 10.10am 31/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |